Trial
NCT04048707
Angiotensin 2 for Hepatorenal Syndrome
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, Los Angeles
Collaborators
—
Condition
Hepatorenal Syndrome
Intervention
Angiotensin II
Why stopped
Funding issues; the study was never started
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-06